The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The protein expression profile of ACE2 in human tissues
Open accessPublished version of a preprint
Abstract
The novel SARS‐coronavirus 2 (SARS‐CoV‐2) poses a global challenge on healthcare and society. For understanding the susceptibility for SARS‐CoV‐2 infection, the cell type‐specific expression of the host cell surface receptor is necessary. The key protein suggested to be involved in host cell entry is angiotensin I converting enzyme 2 (ACE2). Here, we report the expression pattern of ACE2 across > 150 different cell types corresponding to all major human tissues and organs based on stringent immunohistochemical analysis. The results were compared with several datasets both on the mRNA and protein level. ACE2 expression was mainly observed in enterocytes, renal tubules, gallbladder, cardiomyocytes, male reproductive cells, placental trophoblasts, ductal cells, eye, and vasculature. In the respiratory system, the expression was limited, with no or only low expression in a subset of cells in a few individuals, observed by one antibody only. Our data constitute an important resource for further studies on SARS‐CoV‐2 host cell entry, in order to understand the biology of the disease and to aid in the development of effective treatments to the viral infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which in a recent large-scale study based on antibody-based proteomics was shown to be mainly localized to the digestive system, kidney, heart, testis, placenta, eye and upper respiratory epithelia148.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [148]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the heart, ACE2 has been reported to be expressed on cardiomyocytes, pericytes (cells present along the walls of capillaries), and macrophages with lower expression on fibroblasts and endothelial cells.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 2×
“…of ACE2, including gastrointestinal symptoms (Guan et al , 2020), renal failure (preprint: Cheng et al , 2020; preprint: Wang et al , 2020a), cardiac injury (Huang et al , 2020; preprint: Hui et al , 2020a; Zheng et al , 2020), and effects on male gonadal function (preprint: Ma et al , 2020).”
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 1×
“Recent studies suggest that also SARS-CoV-2 employs ACE2 and cellular proteases for host cell entry, including TMPRSS2, CTSB, and CTSL (Hoffmann et al , 2020) and that the affinity between ACE2 and the SARS-CoV-2 S protein interaction is high enough for human transmission (Shang et al , 2020).”
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Self-citationIntegrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 1×
“0 (https://satijalab.org/seurat/9) (Butler et al , 2018) in R (CRAN).”
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“The original report of ACE2 protein expression showed positivity in most tissue and cell types examined, including AT2 cells (Hamming et al , 2004).”
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661 · cited 1×
“Recent studies suggest that also SARS-CoV-2 employs ACE2 and cellular proteases for host cell entry, including TMPRSS2, CTSB, and CTSL (Hoffmann et al , 2020) and that the affinity between ACE2 and the SARS-CoV-2 S protein interaction is high enough for human transmission (Shang et al , 2020).”
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970 · cited 1×
“…of ACE2, including gastrointestinal symptoms (Guan et al , 2020), renal failure (preprint: Cheng et al , 2020; preprint: Wang et al , 2020a), cardiac injury (Huang et al , 2020; preprint: Hui et al , 2020a; Zheng et al , 2020), and effects on male gonadal function (preprint: Ma et al , 2020).”
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
A subcellular map of the human proteome
Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Björk, L., Breckels, L. M., et al. (2017) · Science · doi:10.1126/science.aal3321 · Cited by 2,813
Self-citation
Cited by
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Immune determinants of COVID-19 disease presentation and severity
Brodin, P. (2021) · Nature Medicine · doi:10.1038/s41591-020-01202-8 · Cited by 663
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Müller, J. A., Groß, R., Conzelmann, C., Krüger, J., Merle, U., Steinhart, J., Weil, T., Koepke, L., Bozzo, C. P., Read, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00347-1 · Cited by 552
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Pathophysiology of COVID-19-associated acute kidney injury
Legrand, M., Bell, S., Forni, L., Joannidis, M., Koyner, J. L., Liu, K., & Cantaluppi, V. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00452-0 · Cited by 500
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
Bayati, A., Kumar, R., Francis, V., & McPherson, P. S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100306 · Cited by 499
“Notably, a recent paper questions that ACE2 is the cellular receptor for SARS-CoV-2 based on the observation that immunohistochemical analysis fails to detect ACE2 in cells and tissues that are infectible with virus (44).”
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Stefan, N., Birkenfeld, A. L., & Schulze, M. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00462-1 · Cited by 452
COVID-19 and Cardiovascular Disease: From Bench to Bedside
Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T., Harding, C. V., Kwon, D. H., Singh, T., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 373
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Villapol, S. (2020) · Translational Research · doi:10.1016/j.trsl.2020.08.004 · Cited by 343
“A recent study has reported on the expression pattern of ACE2 across more than 150 different cell types corresponding to all major human tissues and organs based on rigorous immunohistochemical analysis.(55) SARS-CoV-2 also uses the receptors for transmembrane protease serine 2 (TMRPSS2), an enzyme that is also expres…”
Immune-mediated approaches against COVID-19
Florindo, H. F., Kleiner, R., Vaskovich-Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi-Fainaro, R. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0732-3 · Cited by 338
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Amraei, R., Yin, W., Napoleon, M. A., Suder, E. L., Berrigan, J., Zhao, Q., Olejnik, J., Chandler, K. B., Xia, C., Feldman, J., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01537 · Cited by 337
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Zamorano Cuervo, N., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Lempp, F. A., Soriaga, L. B., Montiel-Ruiz, M., Benigni, F., Noack, J., Park, Y.-J., Bianchi, S., Walls, A. C., Bowen, J. E., Zhou, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03925-1 · Cited by 297
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
Bertolini, A., van de Peppel, I. P., Bodewes, F. A. J. A., Moshage, H., Fantin, A., Farinati, F., Fiorotto, R., Jonker, J. W., Strazzabosco, M., Verkade, H. J., et al. (2020) · Hepatology · doi:10.1002/hep.31480 · Cited by 293
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
Changeux, J.-P., Amoura, Z., Rey, F. A., & Miyara, M. (2020) · Comptes Rendus. Biologies · doi:10.5802/crbiol.8 · Cited by 289
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
Ahn, J. H., Kim, J., Hong, S. P., Choi, S. Y., Yang, M. J., Ju, Y. S., Kim, Y. T., Kim, H. M., Rahman, M. T., Chung, M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148517 · Cited by 288
“(38), using immunohistochemistry, showed differential ACE2 protein distribution in various human tissues from the Uppsala Biobank, but its localization was not distinguishable at the single-cell level.”
BackgroundAntibodies to combat viral infections: development strategies and progress
Pantaleo, G., Correia, B., Fenwick, C., Joo, V. S., & Perez, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 279
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Drucker, D. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.016 · Cited by 272
Monocytes and Macrophages in COVID-19
Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 266
“These genes are expressed in a wide range of cells, including nasal and bronchial epithelial cells, enterocytes, cardiomyocytes, vascular and testicular cells, placental trophoblasts, bile duct cells (17, 18) as well as macrophages (19, 20).”
BackgroundACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
Lee, I. T., Nakayama, T., Wu, C.-T., Goltsev, Y., Jiang, S., Gall, P. A., Liao, C.-K., Shih, L.-C., Schürch, C. M., McIlwain, D. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19145-6 · Cited by 263
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
Dong, M., Zhang, J., Ma, X., Tan, J., Chen, L., Liu, S., Xin, Y., & Zhuang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110678 · Cited by 259
“ACE2 and TMPRSS2 could help SARS-CoV-2 entry into the human cells, and it has been showed that ACE2 and TMPRSS2 expressions are widely distributed across human tissues including lung, liver, kidney, heart, brain and multiple digestive tract organs [28,33,147,148].”
Ravindra, N. G., Alfajaro, M. M., Gasque, V., Huston, N. C., Wan, H., Szigeti-Buck, K., Yasumoto, Y., Greaney, A. M., Habet, V., Chow, R. D., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001143 · Cited by 258
The Human Protein Atlas—Spatial localization of the human proteome in health and disease
Digre, A., & Lindskog, C. (2021) · Protein Science · doi:10.1002/pro.3987 · Cited by 244
“…proteins such as cytokines, interleukins, interferons, and chemokines (154), complement and coagulation factors (68), hormones (75), growth factors (33) and enzymes (83), in-depth analysis of the proteins secreted to blood revealed about 100 proteins with unknown functions, and hence potentially…”
BackgroundSelf-citationA Single-Cell RNA Expression Map of Human Coronavirus Entry Factors
Singh, M., Bansal, V., & Feschotte, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108175 · Cited by 241
“Digestive System: Infection Hotspot? Consistent with several studies (Hikmet et al., 2020; Sungnak et al., 2020; Ziegler et al., 2020), we found that the small intestine is one of the ‘‘hottest’’ tissues for co-expression of TMPRSS2 with ACE2, but also for DPP4 and ANPEP as reported previously (Venkatakrishnan et al.”
InfluentialSARS-CoV-2 cell tropism and multiorgan infection
Liu, J., Li, Y., Liu, Q., Yao, Q., Wang, X., Zhang, H., Chen, R., Ren, L., Min, J., Deng, F., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00249-2 · Cited by 235
Stanley, K. E., Thomas, E., Leaver, M., & Wells, D. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.05.001 · Cited by 229
“RNA expression was categorized into groups by the following schema, consistent with that used by Hikmet et al. (20).”
Lamers, M. M., van der Vaart, J., Knoops, K., Riesebosch, S., Breugem, T. I., Mykytyn, A. Z., Beumer, J., Schipper, D., Bezstarosti, K., Koopman, C. D., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105912 · Cited by 227
“Ciliated cells in the airways seem to express ACE2 more constitutively, with increasing expression toward the proximal part of the airway (Hikmet et al , 2020; Hou et al , 2020).”
Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 220
Lu-Culligan, A., Chavan, A. R., Vijayakumar, P., Irshaid, L., Courchaine, E. M., Milano, K. M., Tang, Z., Pope, S. D., Song, E., Vogels, C. B. F., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.016 · Cited by 214
“Recent studies of central nervous system and other tissue confirm that the mRNA level of ACE2 is not a reliable surrogate for ACE2 protein expression.(17,42) ACE2 protein expression is highest in the first trimester and decreases over the course of a healthy pregnancy, indicating potential vulnerability to SARS-CoV-2…”
BackgroundSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
Synowiec, A., Szczepański, A., Barreto-Duran, E., Lie, L. K., & Pyrc, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 212
A high-stringency blueprint of the human proteome
Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210
Self-citationReceptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
Gu, Y., Cao, J., Zhang, X., Gao, H., Wang, Y., Wang, J., He, J., Jiang, X., Zhang, J., Shen, G., et al. (2022) · Cell Research · doi:10.1038/s41422-021-00595-6 · Cited by 206
“S4c), further excluding the possibility that these two factors function through ACE2.”
InfluentialFignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., Marchetti, P., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596898 · Cited by 205
“To specifically detect ACE2 protein in such context, we initially used a previously validated monoclonal anti-human ACE2 antibody (R&D MAB933) (7) which passed the validation criteria suggested by the International Working Group for Antibody Validation (IWGAV) (7,40) (see Resources Table in Supplementary Material).”
MethodResultInfluentialOn the whereabouts of SARS-CoV-2 in the human body: A systematic review
Trypsteen, W., Van Cleemput, J., Snippenberg, W. V., Gerlo, S., & Vandekerckhove, L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009037 · Cited by 199
“To date, there are no reports on the possible presence of SARS-CoV-2 in these organs, although ACE2 expression can be high and is found in liver cholangiocytes, TROP2+ liver progenitor cells, gall bladder epithelium, pancreatic exocrine glands and islets [49, 121, 122].”
BackgroundLeukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
Alon, R., Sportiello, M., Kozlovski, S., Kumar, A., Reilly, E. C., Zarbock, A., Garbi, N., & Topham, D. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00470-2 · Cited by 197
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Madjunkov, M., Dviri, M., & Librach, C. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00737-1 · Cited by 183
“On the other hand, ACE2 expression in the testis is among the highest observed, with high expression in Leydig and Sertoli cells and medium expression in glandular cells of the seminal vesicle [34, 37, 38].”
BackgroundSARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Albornoz, E. A., Amarilla, A. A., Modhiran, N., Parker, S., Li, X. X., Wijesundara, D. K., Aguado, J., Zamora, A. P., McMillan, C. L. D., Liang, B., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01831-0 · Cited by 180
Coate, K. C., Cha, J., Shrestha, S., Wang, W., Gonçalves, L. M., Almaça, J., Kapp, M. E., Fasolino, M., Morgan, A., Dai, C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.006 · Cited by 177
“Raw gene count matrices were extracted from existing single cell RNA-seq datasets (Baron et al., 2016; Camunas-Soler et al., 2020; Segerstolpe et al., 2016) and from the Human Pancreas Analysis Program (HPAP) Database (https://hpap.pmacs.upenn.edu), a Human Islet Research Network consortium.”
InfluentialAguiar, J. A., Tremblay, B. J.-M., Mansfield, M. J., Woody, O., Lobb, B., Banerjee, A., Chandiramohan, A., Tiessen, N., Cao, Q., Dvorkin-Gheva, A., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01123-2020 · Cited by 174
“In general, the promoter activity of ACE2 in airway-related tissues is low or absent; only a single sample originating from an adult lung yields a normalized CAGE promoter expression level above one transcript per million, while expression was observed in gut cells, consistent with known patterns of ACE2 expression[57…”
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
Glebov, O. O. (2020) · The FEBS Journal · doi:10.1111/febs.15369 · Cited by 173
Emerging SARS-CoV-2 variants expand species tropism to murines
Shuai, H., Chan, J. F.-W., Yuen, T. T.-T., Yoon, C., Hu, J.-C., Wen, L., Hu, B., Yang, D., Wang, Y., Hou, Y., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103643 · Cited by 171
Kusmartseva, I., Wu, W., Syed, F., Van Der Heide, V., Jorgensen, M., Joseph, P., Tang, X., Candelario-Jalil, E., Yang, C., Nick, H., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.005 · Cited by 165
“Nevertheless, in our efforts, all four antibodies demonstrated robust and essentially commensurate staining in human duodenum and kidney FFPE sections (Figure S3C), consistent with two recent reports (Hikmet et al., 2020; Lee et al., 2020a).”
InfluentialFlattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
Market, M., Angka, L., Martel, A. B., Bastin, D. J., Olanubi, O., Tennakoon, G., Boucher, D. M., Ng, J., Ardolino, M., & Auer, R. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01512 · Cited by 164
“SARS-CoV-2 viral entrance is thought to be mediated by binding of the S protein to the ACE2 receptor (51, 52), although this is still under debate (53).”
BackgroundTMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
Baggen, J., Jacquemyn, M., Persoons, L., Vanstreels, E., Pye, V. E., Wrobel, A. G., Calvaresi, V., Martin, S. R., Roustan, C., Cronin, N., et al. (2023) · Cell · doi:10.1016/j.cell.2023.06.005 · Cited by 161
“Recombinant ACE2 ectodomain and Wuhan-Hu-1 SARS-CoV-2 S1(1-530) were described previously.”
Ramarao, P., Joshi, G., & Jagadeesh, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109721 · Cited by 162
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died
Aschman, T., Schneider, J., Greuel, S., Meinhardt, J., Streit, S., Goebel, H.-H., Büttnerova, I., Elezkurtaj, S., Scheibe, F., Radke, J., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.2004 · Cited by 159
Hypertension and COVID-19: Current Evidence and Perspectives
Gallo, G., Calvez, V., & Savoia, C. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00506-9 · Cited by 156
“Several studies, however, have demonstrated that ACE2 expression is low in the respiratory tract [61] and that the ACE2/Ang (1–7)/MasR axis exerts an important protective role against inflammatory lung injury, whereas an increased expression of Ang II and the activation AT1R may favor pulmonary damage [62].”
BackgroundSex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
Chakravarty, D., Nair, S. S., Hammouda, N., Ratnani, P., Gharib, Y., Wagaskar, V. G., Mohamed, N., Lundon, D., Dovey, Z. S., Kyprianou, N., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1088-9 · Cited by 160
Role of Hypertension on the Severity of COVID-19: A Review
Peng, M., He, J., Xue, Y., Xue, Y., Liu, S., & Gong, Z. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001116 · Cited by 169
Santos, A., Magro, D. O., Poderoso, R. E., & Saad, M. J. A. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00639-2 · Cited by 151
“It seems that this contradiction can occur due to the difficulty of isolating the islets that can affect the expression of ACE2 [71, 73, 74]”
BackgroundSystematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Puray‐Chavez, M., LaPak, K. M., Schrank, T. P., Elliott, J. L., Bhatt, D. P., Agajanian, M. J., Jasuja, R., Lawson, D. Q., Davis, K., Rothlauf, P. W., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109364 · Cited by 150
“As ACE2 expression is comparably low in the human respiratory system (Aguiar et al., 2020; Hikmet et al., 2020), other co-receptors and/or attachment factors have been suspected to facilitate viral entry.”
Thacker, V. V., Sharma, K., Dhar, N., Mancini, G.-F., Sordet-Dessimoz, J., & McKinney, J. D. (2021) · The EMBO Reports · doi:10.15252/embr.202152744 · Cited by 142
“In ATs, ACE2 expression was low both in monoculture (Fig EV1A) and on-chip (Fig 1E) consistent with transcriptomic (Hou et al, 2020; Qi et al, 2020) and proteomic (Hikmet et al, 2020) analyses of human tissue.”
Endothelial cells are not productively infected by SARS‐CoV‐2
Schimmel, L., Chew, K. Y., Stocks, C. J., Yordanov, T. E., Essebier, P., Kulasinghe, A., Monkman, J. H., Miggiolaro, A. F. R. D. S., Cooper, C. L., de Noronha, L., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1350 · Cited by 141
“This is in line with other studies that showed expression of SARS-CoV-2 receptors by the endothelium in human tissue or in cultured cells.(15,18,24,32) However, we did not detect endothelial cell infection following exposure to 6 9 10(4) PFUs of SARS-CoV-2, whereas epithelial cells were readily infected at the same vi…”
ResultAngiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Oudit, G. Y., Wang, K., Viveiros, A., Kellner, M. J., & Penninger, J. M. (2023) · Cell · doi:10.1016/j.cell.2023.01.039 · Cited by 139
Schuler, B. A., Habermann, A. C., Plosa, E. J., Taylor, C. J., Jetter, C. S., Kapp, M., Benjamin, J. T., Gulleman, P., Nichols, D. S., Braunstein, L. Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140766 · Cited by 139
SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
Yu, S., Zheng, X., Zhou, B., Li, J., Chen, M., Deng, R. X., Wong, G., Lavillette, D., & Meng, G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111199119 · Cited by 140
“…linings of the nasal mucosa, trachea, and bron-chi (45), these human primary respiratory cells are often difficult to obtain, maintain, and manipulate; expression of ACE2 in these primary tissues is also limited (46), hindering the study on how spike mediates membrane fusion in human cells.”
Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus
Xu, J., & Lazartigues, E. D. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00915-1 · Cited by 136
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Bigdelou, B., Sepand, M. R., Najafikhoshnoo, S., Negrete, J. A. T., Sharaf, M., Ho, J. Q., Sullivan, I., Chauhan, P. S., Etter, M. M., Shekarian, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890517 · Cited by 142
The Spike of Concern—The Novel Variants of SARS-CoV-2
Winger, A., & Caspari, T. (2021) · Viruses · doi:10.3390/v13061002 · Cited by 130
“Given the high expression level of Ace2 in the gastrointestinal system [7], it is worth noting that active replicating virus was found in anal samples [77], suggesting that the gastrointestinal system may provide an evolution refuge for SARS-CoV-2.”
BackgroundHejbøl, E. K., Harbo, T., Agergaard, J., Madsen, L. B., Pedersen, T. H., Østergaard, L. J., Andersen, H., Schrøder, H. D., & Tankişi, H. (2022) · European Journal of Neurology · doi:10.1111/ene.15435 · Cited by 134
Marchianò, S., Hsiang, T.-Y., Khanna, A., Higashi, T., Whitmore, L. S., Bargehr, J., Davaapil, H., Chang, J., Smith, E. A., Ong, L. P., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.008 · Cited by 125
“This protein is expressed in different tissues of the human body, including cardiomyocytes and cardiac peri-cytes, and its primary function is to counterbalance the renin-angiotensin-aldosterone system (Chen et al., 2020a; Hikmet et al., 2020; Li et al., 2020; Verdecchia et al., 2020).”
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Thye, A. Y.-K., Law, J. W., Pusparajah, P., Letchumanan, V., Chan, K., & Lee, L. (2021) · Biomedicines · doi:10.3390/biomedicines9101303 · Cited by 133
“In the lungs and the upper airways, the human ACE2 expression is limited to a particular type of cells, such as type 2 alveolar cells in the lungs and goblet cells in the nasal mucosa [100].”
BackgroundTopol, E. J. (2020) · Science · doi:10.1126/science.abe2813 · Cited by 123
Kouwaki, T., Nishimura, T., Wang, G., & Oshiumi, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700926 · Cited by 120
“ACE2 is expressed in various cells and tissue types (22).”
BackgroundSARS-CoV-2, fertility and assisted reproduction
Ata, B., Vermeulen, N., Mocanu, E. V., Gianaroli, L., Lundin, K., Rautakallio-Hokkanen, S., Tapanainen, J. S., & Veiga, A. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac037 · Cited by 127
“In comprehensive studies, ACE2 protein expression has been documented in the testis by immunohistochemistry and compared with transcriptomics, scRNA-seq datasets, western blot and mass spectrometry data (Fu et al., 2020; Hikmet et al., 2020).”
BackgroundMethodThe choroid plexus and its role in the pathogenesis of neurological infections
Thompson, D., Brissette, C. A., & Watt, J. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00372-6 · Cited by 120
“Distribution mapping of the cellular components ACE2 and TMPRSS2 have shown a wide variety of expression in different organs, with expression levels within the brain being lower compared to other organs such as the lungs or small intestines [237, 241, 242].”
BackgroundSong, X., Hu, W., Yu, H., Zhao, L., Zhao, Y., Zhao, X., Xue, H., & Zhao, Y. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24285 · Cited by 117
“The ACE2 expression has been mainly distributed in microvilli of the intestine and renal proximal tubules, gallbladder epithelium, testicular Sertoli cells and Leydig cells, glandular cells of seminal vesicle, and cardiomyocytes [8].”
BackgroundSARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Liu, X., Huuskonen, S., Laitinen, T., Redchuk, T. A., Bogacheva, M. S., Salokas, K., Pöhner, I., Öhman, T., Tonduru, A. K., Hassinen, A., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110396 · Cited by 119
Shiers, S. I., Ray, P. R., Wangzhou, A., Sankaranarayanan, I., Tatsui, C. E., Rhines, L. D., Li, Y., Uhelski, M. L., Dougherty, P. M., & Price, T. J. (2020) · Pain · doi:10.1097/j.pain.0000000000002051 · Cited by 120
“There are many currently unexplained neurological features in patients with COVID-19,16,18 including persistent symptoms such as joint pain and headache linked to nociceptor function.7 It is mysterious how the virus enters the nervous system as most neurons do not express ACE2.”
BackgroundMonocyte activation in systemic Covid-19 infection: Assay and rationale
Martínez, F. O., Combes, T., Orsenigo, F., & Gordon, S. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102964 · Cited by 123
“Macrophages in tuberculosis and sarcoidosis express ACE1 [40], but expression of ACE2 by monocytes and tissue macrophages has not been validated [41]; evidence for productive infection of macrophages via ACE2 is incomplete [15].”
COVID-19–Induced New-Onset Diabetes: Trends and Technologies
Metwally, A. A., Mehta, P., Johnson, B. S., Nagarjuna, A., & Snyder, M. P. (2021) · Diabetes · doi:10.2337/dbi21-0029 · Cited by 118
Severe COVID-19: A multifaceted viral vasculopathy syndrome
MAGRO, C. M. J., Mulvey, J. J., Kubiak, J. M., Mikhail, S., Suster, D. I., CROWSON, A. N., Laurence, J. C., & Nuovo, G. J. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151645 · Cited by 111
“ACE2 deactivates of angiotensin I and angiotensin II, ultimately producing Angiotensin [1-7], a seven-member peptide that opposes the actions of angiotensin I and II through receptor MasR Circulating Angiotensin [1-7] along with apelins, a second product of ACE-2, affects tissues including the endothelium throughout t…”
Qiao, J., Li, W., Bao, J., Peng, Q., Wen, D., Wang, J., & Sun, B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.042 · Cited by 109
“A large-scale immunohistochemical analysis on 45 different human tissues reports that there was not expression of ACE2 in the brain [16].”
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Pizzato, M., Baraldi, C., Sopetto, G. B., Finozzi, D., Gentile, C., Gentile, M. D., Marconi, R., Paladino, D., Raoss, A., Riedmiller, I., et al. (2022) · Frontiers in Virology · doi:10.3389/fviro.2021.815388 · Cited by 118
“In vitro studies have shown that ACE2 expression in pulmonary and olfactory cells is low (119), while NRP1 appears to be abundantly expressed, consistent with an important role of the latter as a coreceptor to enhance cell tropism for the upper respiratory tract.”
BackgroundCOVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Martínez-Salazar, B., Holwerda, M., Stüdle, C., Piragyte, I., Mercader, N., Engelhardt, B., Rieben, R., & Döring, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824851 · Cited by 113
“3 COVID-19 and the Heart According to literature, human cardiomyocytes express only relatively low amounts of ACE2 compared to other heart residing cells such as pericytes or fibroblasts (Chen et al., 2020; Hikmet et al., 2020; Litviňuková et al., 2020; Nicin et al., 2020).”
BackgroundA SARS-CoV-2 – host proximity interactomePreprint
Samavarchi‐Tehrani, P., Abdouni, H. S., Knight, J. D. R., Astori, A., Samson, R., Lin, Z., Kim, D., Knapp, J. J., St‐Germain, J. R., Go, C. D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.03.282103 · Cited by 112
ACE2 and gut amino acid transport
Camargo, S. M. R., Vuille-dit-Bille, R. N., Meier, C. F., & Verrey, F. (2020) · Clinical Science · doi:10.1042/cs20200477 · Cited by 105
Hypertension, a Moving Target in COVID-19: Current Views and Perspectives
Savoia, C., Volpe, M., & Kreutz, R. H. (2021) · Circulation Research · doi:10.1161/circresaha.121.318054 · Cited by 123
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
Zhang, J., Garrett, S., & Sun, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.08.013 · Cited by 109
“They found that ACE2 expression was highest in enterocytes, including the small intestine, colon and duodenum.(42) Similarly, Xu et al also indicated that digestive tract organs had higher ACE2 expression levels compared to the lung based on a series of bulk and single-cell RNA sequencing data.”
InfluentialTargeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
Jia, H., Neptune, E., & Cui, H. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0322ps · Cited by 100
Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2
Sun, K., Gu, L., Ma, L., & Duan, Y. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05850 · Cited by 99
The human protein atlas—Integrated omics for single cell mapping of the human proteome
Digre, A., & Lindskog, C. (2023) · Protein Science · doi:10.1002/pro.4562 · Cited by 98
Self-citationMurta, V., Villarreal, A., & Ramos, A. J. (2020) · ASN NEURO · doi:10.1177/1759091420954960 · Cited by 93
Rahimi, N. (2020) · Biology · doi:10.3390/biology10010001 · Cited by 90
Barhoumi, T., Alghanem, B., Shaibah, H., Mansour, F. A., Alamri, H. S., Akiel, M., Alroqi, F. J., & Boudjelal, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728896 · Cited by 90
“ACE2 is a crucial component of RAS, which is expressed in several cells and organs such as macrophages and endothelial cells (30, 31).”
BackgroundDiabetes and COVID-19; A Bidirectional Interplay
Kazakou, P., Lambadiari, V., Ikonomidis, I., Kountouri, A., Panagopoulos, G. N., Athanasopoulos, S., Korompoki, E., Kalomenidis, I., Dimopoulos, M. A., & Mitrakou, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.780663 · Cited by 96
“This SARS-CoV-2 induced ACE2 under-expression and inflammatory injury seem to be extended in all cells with ACE2 activity, including pancreatic islets (85, 86).”
BackgroundACE2-Independent Alternative Receptors for SARS-CoV-2
Lim, S., Zhang, M., & Chang, T. L.-Y. (2022) · Viruses · doi:10.3390/v14112535 · Cited by 90
“In the lung, for example, ACE2 expression is low abundance and limited to type II alveolar cells (AT2) and ciliated cells [28], yet lung pathology is not limited to these cells.”
BackgroundMakowski, L., Olson-Sidford, W., & Weisel, J. W. (2021) · Viruses · doi:10.3390/v13020146 · Cited by 86
“[13] reported that ACE2 expression in the respiratory tract is limited compared to that in other barrier tissues and observed only very low levels of ACE2 in the normal respiratory system.”
BackgroundPrabhakara, C., Godbole, R. K., Sil, P., Jahnavi, S., Gulzar, S.-E.-J., van Zanten, T. S., Sheth, D., Subhash, N., Chandra, A., Shivaraj, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009706 · Cited by 86
“Transcriptomic and histochemical studies show that the gastrointestinal tract comprises of cell-types differentially expressing ACE2: oesophagus and proximal stomach have undetectable ACE2, distal stomach, duodenum, colon and rectum express high levels [86].”
RdRp mutations are associated with SARS-CoV-2 genome evolution
Eskier, D., Karakülah, G., Süner, A., & Oktay, Y. (2020) · PeerJ · doi:10.7717/peerj.9587 · Cited by 85
Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection
Wang, C., Wang, S., Chen, Y., Zhao, J., Han, S., Zhao, G., Kang, J., Liu, Y., Wang, L., Wang, X., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c06836 · Cited by 85
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
Pasquale, V. D., Quiccione, M. S., Tafuri, S., Avallone, L., & Pavone, L. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126574 · Cited by 87
“Indeed, while ACE2 is expressed at low levels in respiratory and olfactory epithelial cells [120], NRP1 is highly expressed in the respiratory and olfactory epithelium.”
BackgroundData, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing
Zecha, J., Lee, C., Bayer, F. P., Meng, C., Grass, V., Zerweck, J., Schnatbaum, K., Michler, T., Pichlmair, A., Ludwig, C., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002164 · Cited by 85
Kuriakose, J., Montezano, A. C. I., & Touyz, R. M. (2021) · Clinical Science · doi:10.1042/cs20200480 · Cited by 84
Boroujeni, M. E., Simani, L., Bluyssen, H. A. R., Samadikhah, H. R., Benisi, S. Z., Hassani, S., Dilmaghani, N. A., Fathi, M., Vakili, K. G., Mahmoudiasl, G., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00111 · Cited by 87
Extracellular Vimentin as a Target Against SARS‐CoV‐2 Host Cell Invasion
Suprewicz, Ł., Swoger, M., Gupta, S., Piktel, E., Byfield, F. J., Iwamoto, D. V., Germann, D., Reszeć, J., Marcińczyk, N., Carroll, R. J., et al. (2021) · Small · doi:10.1002/smll.202105640 · Cited by 84
Weber, S., Hellmuth, J. C., Scherer, C., Muenchhoff, M., Mayerle, J. V., & Gerbes, A. L. (2021) · Gut · doi:10.1136/gutjnl-2020-323800 · Cited by 83
Cancer vaccines: past, present and future; a review article
Grimmett, E., Al-Share, B. A., Alkassab, M. B., Zhou, R. W., Desai, A., Rahim, M. M. A., & Woldie, I. (2022) · Discover Oncology · doi:10.1007/s12672-022-00491-4 · Cited by 86
“to high expression of ACE2 on epithelial cells in these organs [121].”
Background
Metadata
- Authors
- Hikmet, F., Méar, L., Edvinsson, Å., Micke, P., Uhlén, M., & Lindskog, C.
- Affiliations
- Uppsala University (SE)
- Science for Life Laboratory (SE)
- Corresponding author
- Lindskog, Cecilia
- Venue
- Molecular Systems Biology
- Published
- 2020-07-01
- Volume
- 16
- Issue
- 7
- Pages
- e9610-e9610
- ISSN
- 1744-4292 (ISSN-L)
- PMC
- PMC7383091
- OpenAlex
- W3044069820
- Cited by
- 1,016
- References
- 67
- Citations by year
- 2026: 31 · 2025: 78 · 2024: 123 · 2023: 165 · 2022: 214 · 2021: 275 · 2020: 130
- FWCI
- 25.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 25 d)
- Locations
- Molecular Systems Biology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cancerfonden
- Knut and Alice Wallenberg Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- ACE2, SARS-CoV-2, COVID-19 pandemic, host cell entry, protein expression patterns, human tissue, cell type-specific gene expression, enterocytes, renal tubules, cardiomyocytes, placental trophoblast, respiratory system, host susceptibility
- MeSH terms
- Betacoronavirus, Host Microbial Interactions, RNA-Seq, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Blood Vessels, Conjunctiva, Female, Gallbladder, Humans, Immunohistochemistry, Kidney Tubules, Proximal, Peptidyl-Dipeptidase A, Male, Organ Specificity, Placenta, Pregnancy, Respiratory System, Mass Spectrometry, Testis, Enterocytes, Myocytes, Cardiac, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.